Values as of: 2025-05-06
COMMON STOCK | Medical Care Facilities |
Last Closing
USD 95.05Change
+0.95 (+1.01)%Market Cap
USD 1.42BVolume
0.03MVerdict
Verdict
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| HCA | HCA Holdings Inc |
+4.28 (+1.20%) |
USD 82.48B |
| THC | Tenet Healthcare Corporation |
+0.84 (+0.55%) |
USD 11.78B |
| UHS | Universal Health Services Inc |
+2.43 (+1.32%) |
USD 11.44B |
| DVA | DaVita HealthCare Partners Inc |
+1.34 (+0.94%) |
USD 11.16B |
| EHC | Encompass Health Corp |
+0.46 (+0.39%) |
USD 10.29B |
| CHE | Chemed Corp |
+0.93 (+0.16%) |
USD 8.67B |
| CON | Concentra Group Holdings Paren.. |
+0.17 (+0.78%) |
USD 2.93B |
| ARDT | Ardent Health Partners, Inc. |
+1.20 (+9.22%) |
USD 2.59B |
| AGL | agilon health Inc |
-1.07 (-23.99%) |
USD 1.65B |
| GRDN | Guardian Pharmacy Services, In.. |
+0.13 (+0.51%) |
USD 1.25B |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| COAL | Exchange Traded Concepts .. | 4.92 % | 0.00 % |
-0.14 (-0.81%) |
USD 0.01B |
| SDGPEX:SW | iShares STOXX Global Sele.. | 2.12 % | 0.00 % |
N/A |
N/A |
| D100:XETRA | 2.01 % | 0.00 % |
N/A |
N/A | |
| DESC | 0.00 % | 0.30 % |
N/A |
N/A | |
| KOL | 0.00 % | 0.60 % |
N/A |
N/A | |
| ISPA:F | iShares (DE) I - iShares .. | 0.00 % | 0.00 % |
+0.03 (+-0.81%) |
N/A |
| ISPA:XETRA | iShares STOXX Global Sele.. | 0.00 % | 0.00 % |
-0.07 (-0.81%) |
N/A |
| MVS:AU | VanEck Vectors Small Comp.. | 0.00 % | 0.00 % |
+0.17 (+-0.81%) |
USD 0.07B |
| Market Performance vs. Industry/Classification (Medical Care Facilities) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -11.63% | 35% | F | 21% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -11.63% | 35% | F | 20% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | 1.40% | 61% | D- | 54% | F | ||
| Dividend Return | 1.95% | 78% | C+ | 38% | F | ||
| Total Return | 3.35% | 61% | D- | 47% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | 47.05% | 53% | F | 55% | F | ||
| Dividend Return | 16.54% | 100% | F | 43% | F | ||
| Total Return | 63.58% | 53% | F | 52% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 17.71% | 68% | D+ | 81% | B- | ||
| Dividend Return | 20.86% | 77% | C+ | 82% | B | ||
| Total Return | 3.15% | 100% | F | 65% | D | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 35.10% | 50% | F | 26% | F | ||
| Risk Adjusted Return | 59.44% | 91% | A- | 73% | C | ||
| Market Capitalization | 1.42B | 57% | F | 64% | D | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
